Live
- Woman’s False Claim Sparks Unnecessary Panic
- Locals Report Naxal Activity in Karkala Village
- Mangaluru International Airport Sets New Records in Passenger and Flight Movements
- Where Areca failed, grow Coffee
- Collector Badavath Santosh Reviews Household Survey and Listing Process
- Awareness Session on SHE Team and POCSO Act
- Awareness Program in agricultural College on the Dangers of Drug Abuse for Youth
- 3500-Year-Old Menhir in Kamsanpally Village: A Call for Preservation
- The Role of Artificial Intelligence in Radiology: Transforming Diagnosis and Patient Care
- Hindustan Zinc Ltd. Signs MoU with Rajasthan Government to Invest Rs 36 Crores in Education Development
Hyderabad: Envoys of 80 countries to visit covid vaccine centre at Bharat Biotech today
Envoys of 80 countries to visit covid vaccine centre at Bharat Biotech today
Ambassadors and high commissioners of around 80 foreign countries to visit COVID-19 vaccine centre at Bharat Biotech and BE limited today.
Ambassadors and high commissioners of around 80 foreign countries to visit COVID-19 vaccine centre at Bharat Biotech and BE limited today. The visit is organised by the Ministry of External Affairs. The one-day visit of the foreign dignitaries has been planned to familiarise them with vaccine preparation, production opportunities and the vaccine distribution plan.
The team will arrive in Hyderabad at 10 am today. State Chief Secretary Somesh Kumar along with Chief of Protocol Nagesh Singh and other senior officials has already made arrangements for the foreign team's visit to Hyderabad. The CS directed the authorities to provide well-equipped buses, a special medical team. "A presentation should also be made to showcase the state's potential in the production and supply of vaccine and should also include the Pharma City and Genome Valley," according to the official release.
Last week, Prime Minister Narendra Modi visited the Bharat Biotech vaccine centre to review the developmental work on the coronavirus vaccine.
At present, the Covaxin developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) is under Phase-III of clinical trials. The human trials of the vaccine are being conducted at Nizam's Institute of Medical Sciences (ICMR).
